Discovery of first-in-class NSD2 degraders for cancer therapy

Active Project Grant Awarded Last action

Award ID
R01CA242305
Recipient
Awarding agency
Obligated
$2,367,638

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date 90% complete
Originally
Funding
  • $2,179,328.00 Federal
  • $188,310.00 Non-federal
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $138,700 $0
Amendment $327,284 $0
Amendment $327,458 $0
Amendment $327,458 $0
Amendment $188,310 $0
Amendment $188,310 $188,310
Amendment $334,476 $0
Original award $347,332 $0

Subawards

Subrecipient Amount Awarded
The Governing Council Of The University Of Toronto In support of the project, the University of Toronto will provide in vitro and cellular assays and screening resources to assess ligand binding to NSD2 and… $35,460
The Governing Council Of The University Of Toronto $141,840

Quick answers

Who received award R01CA242305?

R01CA242305 was awarded to University Of North Carolina At Chapel Hill by National Cancer Institute (National Institutes of Health) on August 23, 2019.

How much is award R01CA242305 worth?

$2,367,638 has been obligated on R01CA242305: $2,179,328 in federal funding and $188,310 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award